Literature DB >> 15754066

Economic evidence in affective disorders: a review.

Mickael Löthgren1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15754066     DOI： 10.1007/s10198-005-0283-4

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  7 in total

1.  Cost-effectiveness of In-Home Cognitive Behavioral Therapy for low-income depressed mothers participating in early childhood prevention programs.

Authors:  Robert T Ammerman; Peter J Mallow; John A Rizzo; Frank W Putnam; Judith B Van Ginkel
Journal:  J Affect Disord       Date:  2016-11-03       Impact factor: 4.839

Review 2.  Cost-of-illness studies for bipolar disorder: systematic review of international studies.

Authors:  Huajie Jin; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

3.  Psychosocial working conditions and depressive symptoms among Swedish employees.

Authors:  Linda L Magnusson Hanson; Töres Theorell; Per Bech; Reiner Rugulies; Hermann Burr; Martin Hyde; Gabriel Oxenstierna; Hugo Westerlund
Journal:  Int Arch Occup Environ Health       Date:  2009-02-24       Impact factor: 3.015

4.  Cost of disorders of the brain in Italy.

Authors:  Maura Pugliatti; Patrik Sobocki; Ettore Beghi; Stefano Pini; Giovanni B Cassano; A Carlo Altamura; Sara Pozzoli; Giulio Rosati
Journal:  Neurol Sci       Date:  2008-05-16       Impact factor: 3.307

5.  [Cost of disorders of the brain in Austria in the year 2004].

Authors:  Johannes Wancata; Patrick Sobocki; Heinz Katschnig
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  Within-trial economic evaluation of diabetes-specific cognitive behaviour therapy in patients with type 2 diabetes and subthreshold depression.

Authors:  Nadja Chernyak; Bernd Kulzer; Norbert Hermanns; Andreas Schmitt; Annika Gahr; Thomas Haak; Johannes Kruse; Christian Ohmann; Marsel Scheer; Guido Giani; Andrea Icks
Journal:  BMC Public Health       Date:  2010-10-19       Impact factor: 3.295

7.  Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA).

Authors:  Nadja Chernyak; Frank Petrak; Kristin Plack; Martin Hautzinger; Matthias J Müller; Guido Giani; Andrea Icks
Journal:  BMC Geriatr       Date:  2009-07-01       Impact factor: 3.921
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.